青光眼治疗市场规模预计将从 2022 年的 62.4 亿美元增至 2031 年的 80.2 亿美元。预计 2021-2031 年市场复合年增长率为 3.2%。新型药物输送方法和联合疗法的开发可能仍是青光眼治疗市场的主要趋势。
青光眼治疗市场分析
青光眼是一组眼部疾病,其特征是神经组织逐渐丧失,如果不及时治疗,最终会导致视力丧失。前列腺素类似物是能够通过促进眼部引流来有效降低眼压的药物之一。青光眼患病率的飙升和产品上市的增加预计将有利于青光眼治疗市场的增长。
青光眼治疗市场概况
全球人口老龄化导致青光眼发病率不断上升,为青光眼治疗市场增长创造了巨大机遇。由于老龄人口对青光眼的易感性更高,对创新疗法和管理策略的需求正在上升。此外,定期进行眼科检查对于早期发现和管理青光眼的重要性 增加了患者的参与度和对先进治疗的需求。随着医疗保健系统满足老龄人口的需求,对青光眼研究、开发和治疗机会的投资预计将在未来几年推动市场增长。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
青光眼治疗市场驱动因素和机遇
青光眼疾病增多 市场利好
根据青光眼研究基金会的数据,到 2022 年,全球将有约 8000 万人患青光眼。2010 年,全球有近 840 万人因原发性开角型青光眼而失明。根据青光眼研究基金会的数据,到 2040 年,这一数字预计将增加到 2200 万。预计这将在未来一段时间内增加对青光眼治疗的需求。全球人口中青光眼发病率的上升是全球青光眼治疗市场的主要驱动力。
可穿戴技术的发展——青光眼治疗定制化的机会
青光眼是导致失明的主要原因,早期发现和治疗至关重要。可穿戴青光眼诊断和治疗已成为潜在的解决方案。传统诊断技术可提供可靠的眼压数据,但 Sensimed Triggerfish 等新兴隐形眼镜可提供持续的眼压跟踪。对于治疗,药物洗脱隐形眼镜正成为一种潜在的解决方案。治疗诊断平台将诊断和治疗功能整合到一个设备中,以提供实时监控和个性化药物剂量。
青光眼治疗市场报告细分分析
有助于得出青光眼治疗市场分析的关键部分是药物类别、适应症和分销渠道。
- 根据药物类别,青光眼治疗市场分为β受体阻滞剂、α-肾上腺素能激动剂、前列腺素类似物、碳酸酐酶抑制剂、复方药物等。前列腺素类似物在 2023 年占据最大的市场份额。
- 市场按适应症细分为开角型青光眼、闭角型青光眼和其他类型。开角型青光眼在 2023 年占据了最大的市场份额。
- 就分销渠道而言,市场分为医院药房、零售药房和网上药房。2023 年,医院药房占据了市场主导地位。
青光眼治疗市场份额按地区分析
青光眼治疗市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。
2022 年,近 270 万美国人患有开角型青光眼;青光眼是美国不可逆失明的主要原因。由于该地区青光眼发病率不断上升,北美在 2022 年占据了最大的份额。对新型联合疗法和微创青光眼治疗的日益青睐以及北美主要市场参与者的存在是该地区青光眼治疗市场增长的因素。
青光眼治疗市场区域洞察
Insight Partners 的分析师已详尽解释了预测期内影响青光眼治疗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的青光眼治疗市场细分和地理位置。
- 获取青光眼治疗市场的区域特定数据
青光眼治疗市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 62.4 亿美元 |
2031 年市场规模 | 80.2亿美元 |
全球复合年增长率(2021 - 2031 年) | 3.2% |
史料 | 2021-2022 |
预测期 | 2023-2031 |
涵盖的领域 | 按药物类别
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
青光眼治疗市场参与者密度:了解其对业务动态的影响
青光眼治疗市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在青光眼治疗市场运营的主要公司有:
- 爱尔康公司
- 艾伯维公司
- 博士伦公司
- Fera Pharmaceuticals, LLC
- 维他命公司
- 诺华公司
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解青光眼治疗市场顶级关键参与者概况
青光眼治疗市场新闻和最新发展
青光眼治疗市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是青光眼治疗市场的发展列表:
- 美国食品药品监督管理局 (FDA) 批准了 Glaukos Corporation 的新药申请 (NDA),该申请允许每只眼睛单次注射 iDose TR(曲伏前列素前房植入物)75 mcg,这是一种前列腺素类似物,用于降低眼高压 (OHT) 或开角型青光眼 (OAG) 患者的眼压 (IOP)。(来源:Glaukos Corporation,公司新闻,2023 年)
- 爱尔康宣布收购 Aerie Pharmaceuticals, Inc. 通过此次交易,该公司收购了 Rocklatan(奈他舒地尔和拉坦前列素滴眼液)0.02%/0.005% 和 Rhopressa(奈他舒地尔滴眼液)0.02%,以及用于治疗干眼症的 3 期候选产品 AR-15512 和一系列临床和临床前眼科候选药物。Rocklatan 和 Rhopressa 是 Rho-激酶抑制剂,用于降低开角型青光眼或眼高压患者的眼压升高。此次收购预计将扩大爱尔康在青光眼、视网膜和眼表疾病领域的产品组合。(来源:爱尔康,新闻稿,2022 年)
青光眼治疗市场报告覆盖范围和交付成果
“青光眼治疗市场规模和预测(2022-2031)”报告对以下领域进行了详细的市场分析:
- 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
- 市场动态,如驱动因素、限制因素和关键机遇
- 未来的主要趋势
- 详细的 PEST 和 SWOT 分析
- 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
- 详细的公司简介
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The glaucoma therapeutics market by drug class, is divided into beta blockers, alpha-adrenergic agonists, prostaglandin analogs, carbonic anhydrase inhibitors, combination drugs, and others. The prostaglandin analogs segment held a larger market share in 2023.
The glaucoma therapeutics market majorly consists of the players, including Inoteck Pharmaceuticals; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; Santen Pharmaceutical Co., Ltd.; Teva Pharmaceutical Industries Ltd; Takeda Pharmaceutical Company; AstraZeneca PLC; AERIE Pharmaceuticals, Inc.; and Cipla Inc.
Key factors driving the glaucoma therapeutics informatics growth are the surging prevalence of glaucoma and increasing product launches.
Glaucoma is a group of eye disorders characterized by the gradual loss of nerve tissue that would eventually lead to vision loss if left untreated. Prostaglandin analogs are among the drugs that are highly effective in reducing eye pressure by promoting better drainage from the eye.
The glaucoma therapeutics informatics was valued at US$ 6.24 billion in 2023.
The glaucoma therapeutics market is expected to be valued at US$ 8.02 billion in 2031.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Glaucoma Therapeutics Market
- Fera Pharmaceuticals
- GlaxoSmithKline plc
- Bristol Myers Squibb
- Eli Lilly and Company
- Amgen
- MannKind Corporation
- Sangamo Therapeutics
- SciClone Pharmaceuticals, Inc.
- Critical Therapeutics, Inc.
- Takeda Pharmaceutical Company
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.